CRISPR/Cas9 for Sickle Cell Disease: Applications, Future Possibilities, and Challenges
Selami Demirci(National Institutes of Health), John F. Tisdale(National Heart Lung and Blood Institute), Alexis Leonard(St. Jude Children's Research Hospital), Naoya Uchida(National Heart Lung and Blood Institute), Juan J. Haro‐Mora(National Institutes of Health)
Cited by 62
Related Papers
Antimicrobial Properties of Zeolite-X and Zeolite-A Ion-Exchanged with Silver, Copper, and Zinc Against a Broad Range of Microorganisms
|Applied Biochemistry and Biotechnology|2013|173
Boron and Poloxamer (F68 and F127) Containing Hydrogel Formulation for Burn Wound Healing
|Biological Trace Element Research|2015|114
Gene therapy for sickle cell disease: An update
|Cytotherapy|2018|114
Boron promotes streptozotocin-induced diabetic wound healing: roles in cell proliferation and migration, growth factor expression, and inflammation
|Molecular and Cellular Biochemistry|2016|101
Hematopoietic stem cells from pluripotent stem cells: Clinical potential, challenges, and future perspectives
|Stem Cells Translational Medicine|2020|82